Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Dexivacaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN4A known ✓ | P35499 | 1/20 | 0.46 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mepivacaine SCHEMBL25314 | 1.00 | KCNK3 (0.72) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL34246 | 1.00 | KCNK3 (0.72) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL1131771 | 0.99 | KCNK3 (0.70) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Dexivacaine SCHEMBL34247 | 0.99 | KCNK3 (0.70) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL34245 | 0.99 | KCNK3 (0.70) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL5685622 | 0.99 | KCNK3 (0.70) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL30335090 | 0.99 | KCNK3 (0.70) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL2565234 | 0.99 | KCNK3 (0.70) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| Mepivacaine SCHEMBL2553896 | 0.97 | KCNK3 (0.69) | KCNK3LMNACYP3A4CYP2D6KCNH2 | |
| SCHEMBL18485518 | 0.96 | CYP3A4 (0.74) | KCNK3LMNACYP3A4CYP2D6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18566 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-28 | — | — | US | claimed |
| US-20260137637-A1 | ANESTHETIC AGENT MICRO AND NANO PARTICLES, AND METHODS OF MAKING AND USING THE SAME | HAAS ERIC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743122-A1 | THERAPEUTIC SEALANTS BASED UPON DRUG CONJUGATES | The Johns Hopkins University (US) | 2026-05-20 | — | — | EP | claimed |
| US-12622873-B2 | Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2026-05-12 | — | — | US | claimed |
| EP-4735042-A1 | MERCERIZED DECELLULARIZED PARTICLES FOR SLOW RELEASE APPLICATIONS AND METHODS THEREOF | Spiderwort Biotechnologies Inc. (CA) | 2026-05-06 | — | — | EP | claimed |
| EP-4734906-A1 | METHOD FOR SUCCESSIVE, PRESSURE-DRIVEN DISPENSATION OF SINGLE DOSES OF A MULTIPHASIC MIXTURE WITH CONTROLLED CONCENTRATION AND DOSE FROM A LARGER RESERVOIR TO SMALLER RECIPIENTS AND APPARATUS FOR PERFORMING THE METHOD | Volumina Medical SA (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | UNIV KOREA RES & BUS FOUND (KR) | 2026-04-30 | — | — | US | claimed |
| EP-3723819-B1 | WOUND DRESSING | ANIMAL ETHICS PTY LTD (AU) | 2026-04-22 | — | — | EP | claimed |
| US-20260091007-A1 | PHARMACEUTICAL TOPICAL FORMULATIONS OF LIDOCAINE AND KETAMINE | SOIN AMOL (US) | 2026-04-02 | — | — | US | claimed |
| US-20260083666-A1 | METHOD OF TREATING DISEASE | CREWS THOMAS M (US) | 2026-03-26 | — | — | US | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| EP-0103911-A1 | Emollient-containing topical pharmaceutical compositions | THE PROCTER & GAMBLE COMPANY (US) | 1984-03-28 | — | — | EP | claimed |
| EP-0043738-A2 | Penetrating topical pharmaceutical compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-01-13 | — | — | EP | claimed |
| EP-0002425-B1 | LOCAL ANESTHETIC MIXTURE FOR TOPICAL APPLICATION, AND PROCESS FOR ITS PREPARATION | Astra Läkemedel Aktiebolag (SE) | 1981-11-11 | — | — | EP | claimed |
| EP-0002426-B1 | ANTIPERSPIRANT | Playtex-Wallco Aktiebolag (SE) | 1981-10-07 | — | — | EP | claimed |
| EP-0002426-A1 | Antiperspirant | Playtex-Wallco Aktiebolag (SE) | 1979-06-13 | — | — | EP | claimed |
| EP-0002425-A1 | Local anesthetic mixture for topical application, and process for its preparation | Astra Läkemedel Aktiebolag (SE) | 1979-06-13 | — | — | EP | claimed |
| US-4041174-A | INJECTING AN ESTER LOCAL ANESTHETIC | ROM-AMER PHARMACEUTICALS, LTD. (US) | 1977-08-09 | — | — | US | claimed |
| US-4029793-A | TETRODOXIN OR DESOXYTETRODOXIN | ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) | 1977-06-14 | — | — | US | claimed |
| US-4001413-A | PHARMACEUTICAL LOCAL ANESTHETIC COMPOSITION EMPLOYING SAXITOXIN | ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) | 1977-01-04 | — | — | US | claimed |